- Investigators
- John S Anderson, Jason A Piraino
- Ages
- 18 Years - N/A
- Sexes
- All
Clinical trials
-
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease) -
The Bridging Antiplatelet Therapy with Cangrelor 2 (BRIDGE 2) Study: A Pilot Prospective Cohort, Pharmacodynamic Study of Tailored Cangrelor Bridging Dosing Regimens - Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All